A premier research center serving as a nodal institution for all activities related to cancer in the country and with linkages to Regional Cancer Centers and other cancer centers/institutes within the country and around the world.
Many unanswered questions still remain in the quest to conquer this deadly disease. We have an urgent need to understand the various causes specific to our country and Africa at large. We require more understanding and research for their causation and treatment
However, in order to ascertain the etiology of complex diseases, it is necessary to have access to a wide collection of biological samples with epidemiological, clinical, biological and molecular data from a large number of patients and healthy persons.
WHAT WE DO
PATHOLOGIST EVALUATION OF TISSUE
END TO END TISSUE PROCESSING AND EVALUATION
CREATE NETWORK THAT ALLOWS A MULTI-CENTER EXCHANGE OF SPECIMEN, DATA
COLLECT AND STORE RESIDUAL TISSUES FROM DIFFERENT CENTERS
RESEARCH COLLABORATION
ROUTINE AND SPECIAL LAB INVESTIGATIONS
OUR PARTNERS
PROSTATE CANCER TRANSATLANTIC CONSORTIUM (CaPTC)
The Prostate Cancer Transatlantic Consortium (CaPTC) was formed in 2005 to address the globally disproportionate burden of prostate cancer among Black men. CaPTC is an open consortium comprising a team of prostate cancer scientists, clinicians, survivors, and advocates from North America, Europe, the Caribbean Islands, and West Africa.
CaPTC’s research goals are to:
AFRICAN CARIBBEAN CANCER CONSORTIUM (AC3)
The African-Caribbean Cancer Consortium was formed in May 2006 to further the study of viral, genetic, environmental and lifestyle risk factors for cancer in populations of African descent.Camille Ragin PhD, MPH is responsible for the establishment and development of the consortium. A growing number of dedicated researchers based in the United States, Africa and the Caribbean have joined.
Our Mission – To study viral, genetic, environmental, and lifestyle factors for cancer risk and outcomes in populations of African descent
In recent years, human biological material (e.g. tissues, cells, nucleic acids) obtained through common diagnostic procedures has become an important resource for biomedical research. In oncology, tumor tissue samples represent a precious tool for both clinical and experimental research. These tissues, preserved in optimal conditions, are an essential resource for identifying novel biomarkers for specific therapies.